We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+12.56%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$53.7B
AUM Growth
+$4.94B
(+10%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
0.43%
Top 10 Holdings %
Top 10 Hldgs %
26.8%
Holding
1,539
New
66
Increased
528
Reduced
500
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$157M |
| 2 |
Verizon
VZ
|
+$140M |
| 3 |
Apple
AAPL
|
+$117M |
| 4 |
KLA
KLAC
|
+$115M |
| 5 |
Dell
DELL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XRTX
XORTX Therapeutics
XRTX
|
+$161M |
| 2 |
L3Harris
LHX
|
+$104M |
| 3 |
Voya Financial
VOYA
|
+$99.6M |
| 4 |
BCE
BCE
|
+$88.6M |
| 5 |
NVIDIA
NVDA
|
+$87.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.6% |
| 2 | Healthcare | 16.46% |
| 3 | Financials | 10.3% |
| 4 | Industrials | 9.81% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Myriad Genetics
MYGN
$303M
| $751K | ﹤0.01% |
35,272
+2,980
| +9% | +$64.1K |
|
927
EPR Properties
EPR
$4.73B
| $747K | ﹤0.01% |
17,938
-39,698
| -69% | -$1.73M |
|
928
Victory Capital Holdings
VCTR
$7.27B
| $744K | ﹤0.01% |
17,751
| – | – |
|
929
Ardelyx
ARDX
$1.01B
| $743K | ﹤0.01% |
100,000
| – | – |
|
930
Supernus Pharmaceuticals
SUPN
$2.74B
| $743K | ﹤0.01% |
22,200
-9,575
| -30% | -$285K |
|
931
Crown Holdings
CCK
$12.9B
| $733K | ﹤0.01% |
9,363
-4,684
| -33% | -$383K |
|
932
Academy Sports + Outdoors
ASO
$3.03B
| $726K | ﹤0.01% |
10,715
+296
| +3% | +$20K |
|
933
GFL Environmental
GFL
$15B
| $724K | ﹤0.01% |
20,933
+130
| +0.6% | +$4.49K |
|
934
EyePoint Inc
EYPT
$1.16B
| $718K | ﹤0.01% |
35,000
| – | – |
|
935
Liberty Energy
LBRT
$3.45B
| $718K | ﹤0.01% |
35,248
+30,000
| +572% | +$593K |
|
936
Algonquin Power & Utilities
AQN
$4.48B
| $709K | ﹤0.01% |
114,834
-101,181
| -47% | -$613K |
|
937
Tanger
SKT
$4.42B
| $709K | ﹤0.01% |
23,981
| – | – |
|
938
Hyatt Hotels
H
$16.9B
| $704K | ﹤0.01% |
4,393
+31
| +0.7% | +$4.37K |
|
939
Werner Enterprises
WERN
$2.31B
| $702K | ﹤0.01% |
18,258
-208,713
| -92% | -$8.32M |
|
940
Xencor
XNCR
$1.71B
| $701K | ﹤0.01% |
31,800
| – | – |
|
|
BCYC
941
Bicycle Therapeutics
BCYC
$279M
| $700K | ﹤0.01% |
30,000
| – | – |
|
942
AES
AES
$10.5B
| $699K | ﹤0.01% |
40,871
+2,327
| +6% | +$38.9K |
|
943
PTC Therapeutics
PTCT
$6.01B
| $695K | ﹤0.01% |
24,000
| – | – |
|
944
U-Haul Holding Co Series N
UHAL.B
$12.6B
| $695K | ﹤0.01% |
10,811
-5,596
| -34% | -$361K |
|
945
HUTCHMED
HCM
$2.11B
| $688K | ﹤0.01% |
41,362
-45,181
| -52% | -$686K |
|
|
MPT
946
Medical Properties Trust
MPT
$2.51B
| $678K | ﹤0.01% |
143,910
-92,270
| -39% | -$353K |
|
947
Innovative Industrial Properties
IIPR
$1.67B
| $675K | ﹤0.01% |
6,473
| – | – |
|
948
Bank OZK
OZK
$5.7B
| $669K | ﹤0.01% |
14,738
| – | – |
|
949
Broadstone Net Lease
BNL
$4.35B
| $667K | ﹤0.01% |
44,455
| – | – |
|
950
CAE Inc. Common Shares
CAE
$8.47B
| $666K | ﹤0.01% |
32,646
+1,025
| +3% | +$20.6K |
|
Similar funds
NAMI
DekaBank Deutsche Girozentrale's Q1 2024 Portfolio in Review
As of Q1 2024, DekaBank Deutsche Girozentrale held 1,539 positions worth $53.7B, up 10% from $48.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
DekaBank Deutsche Girozentrale's Q1 2024 filing shows 66 new, 528 increased, 500 reduced and 103 closed positions. Its largest new stake was Flutter Entertainment: 112,763 shares worth $22.5M. The largest sale was XORTX Therapeutics, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- DekaBank Deutsche Girozentrale's largest Q1 2024 buy was Flutter Entertainment: 112,763 shares worth $22.5M.
- DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q1 2024, an estimated $157M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2024 reduction was Voya Financial, cutting an estimated $99.6M.
- DekaBank Deutsche Girozentrale fully exited XORTX Therapeutics in Q1 2024, selling an estimated $161M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 27% of its $53.7B portfolio in Q1 2024.
- DekaBank Deutsche Girozentrale opened 66 new positions and closed 103 in Q1 2024.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $53.7B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2024, filed 24 Apr 2024.